South Korea Heparin Market Insight
Published: 01 August 2026 | Report Format: Electronic (PDF) | Author: Komal and Radhika
The market for heparin in South Korea is anticipated to develop at a compound annual growth rate of 4.93% due to an increase in surgical procedures and cardiovascular illnesses.
South Korea Heparin Market Insights Forecasts to 2035
- The South Korea Heparin Market Size Was Estimated USD 167.3 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 4.93% from 2025 to 2035
- The South Korea Heparin Market Size is Expected to rise around USD 270.6 Million by 2035
Notable Insights for the South Korea Heparin Market
- Low Molecular Weight Heparin (LMWH) dominates the market according to type segmentation, but Unfractionated Heparin maintains a sizable market share for surgical applications.
- According to application segmentation, the most common condition is venous thromboembolism, which is followed by coronary artery disease and atrial fibrillation, which are caused by lifestyle disorders and an aging population.
- Heparin demand is directly supported by the fact that cardiovascular illnesses continue to be a major cause of death in South Korea, where over 30% of patients need anticoagulant medication.
- In 2023, the South Korean heparin market brought in about USD 167.6 million, with hospital pharmacies making up most distribution channels.
Download the eBook (ToC)
Why Buy This Report
- By giving information about the heparin market in South Korea including past trends what it is worth right now and what it might be worth from 2025 to 2035 it helps with making smart choices, about where to invest money.
- To help people who work in the Korean pharmaceutical industry find places where there is a lot of growth the research gives a full breakdown of different types of products how they are used and who uses them.
- With its thorough competitive landscape analysis, businesses may effectively target the most profitable end-use sectors, such as clinics, hospitals, and ambulatory care facilities.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea heparin market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Heparin Market
- Baxter International Inc.
- B. Braun Medical Inc.
- Fresenius SE & Co KGaA
- Dr. Reddy's Laboratories
- Pfizer Inc.
- Sanofi SA
- Novartis AG
- Aspen Pharmacare Holdings Ltd
- Teva Pharmaceutical Industries
- LEO Pharma
Recent Developments:
- In July 2025, B. Braun added two versions of Heparin Sodium Injection, expanding the selection of injectable anticoagulants that hospitals and healthcare professionals around the world can use.
- In September 2024, Fresenius made injectable pharmaceuticals easier to get by growing its network of hospital partnerships across Asia-Pacific helping more people have access to medicines and infusion medicines.
Market Segmentation:
South Korea Heparin Market, By Type
- Low Molecular Weight Heparin (LMWH)
- Ultra-Low Molecular Weight Heparin (ULMWH)
- Unfractionated Heparin (UFH)
South Korea Heparin Market, By Application
- Venous Thromboembolism
- Coronary Artery Disease
- Atrial Fibrillation
- Renal Impairment
South Korea Heparin Market, By End Use
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
Expert Views:
The South Korea heparin market is going to have growth for a long time. This is because more people in South Korea are getting disease there are more surgeries happening and the population is getting older. This means the South Korea heparin market will keep getting bigger until 2035. The South Korea heparin market will have growth because of these things. The South Korea heparin market is important, for people who need these medicines.
Author: Komal and Radhika By Decisions Advisors and Consulting